NZZ | The biodiversity of our planet, an important source of inspiration for pharmaceutical breakthroughs, is at a critical point. Its preservation will determine whether the pharmaceutical industry can continue to launch life-saving innovations in the future. Jessica Browning, Pharmaceuticals Strategist at Quantis sat down with NZZ to share insights on how the industry needs to consider biodiversity as a strategic necessity.
Latest resources
Why an environmental sustainability strategy without nature is incomplete
Businesses have an essential role to play in reversing the trend of nature loss — and a lot to lose from inaction.
Purpose: The 5th ‘P’ in the sustainable food + beverage marketing ...
The 5th 'P' in the marketing mix, purpose, adds depth to product, price, place, and promotion, enabling greater sustainability and impact.
3 key priorities for the sustainable transformation of the chemical se...
Quantis experts have identified 3 pivotal pillars that will play a critical role in shaping the future of sustainable Chemistry.
